Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early warning, prediction, and prevention of acute high-altitude illnesses in Western Sichuan
ChiCTR2400092772Phase 4Not yet recruiting
- Sponsor
- Ya'an People's Hospital
- Start
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of acetazolamide in high altitude illness (4 arms), sponsored by Ya'an People's Hospital. Primary endpoints: Composite efficacy outcome, Acetazolamide-related adverse reactions and 1 more. Planned start Nov 2024; status: not yet recruiting.
02
Drugs
acetazolamide
03
Conditions
high altitude illness
Beyond the preview
Go deeper on ChiCTR2400092772.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400092772.